Phase 0/I/II Cancer Prevention Clinical Trials Program Clinical Trials

Titlesort descending Intervention NCT ID Sponsor Status
Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma Aspirin, Laboratory Biomarker Analysis, Placebo, Questionnaire Administration NCT02965703 National Cancer Institute (NCI) Recruiting
Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful... Aspirin, Laboratory Biomarker Analysis, Placebo, Questionnaire Administration NCT02521285 National Cancer Institute (NCI) Active, not recruiting
Atorvastatin Calcium, Oligofructose-Enriched Inulin, or Sulindac in Preventing Cancer in Patients... oligofructose-enriched inulin, sulindac, placebo, atorvastatin calcium, laboratory biomarker analysis NCT00335504 National Cancer Institute (NCI) Completed
Berberine Chloride in Preventing Colorectal Cancer in Patients With Ulcerative Colitis in Remission Berberine Chloride, Laboratory Biomarker Analysis, Placebo NCT02365480 National Cancer Institute (NCI) Active, not recruiting
Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer Bexarotene, Laboratory Biomarker Analysis, Questionnaire Administration NCT03323658 National Cancer Institute (NCI) Recruiting
Broccoli Sprout/Broccoli Seed Extract Supplement in Decreasing Toxicity in Heavy Smokers Broccoli Sprout/Broccoli Seed Extract Supplement, Laboratory Biomarker Analysis, Questionnaire Administration NCT03402230 National Cancer Institute (NCI) Recruiting
Budesonide in Treating Patients With Lung Nodules at High Risk of Developing Lung Cancer Budesonide, Placebo NCT00321893 National Cancer Institute (NCI) Completed
Cholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate Cancer Cholecalciferol, Genistein, Laboratory Biomarker Analysis, Pharmacological Study, Placebo NCT01325311 National Cancer Institute (NCI) Completed
Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric... Curcumin, Laboratory Biomarker Analysis, Placebo, Quality-of-Life Assessment NCT02782949 National Cancer Institute (NCI) Recruiting
Defined Green Tea Catechin Extract in Preventing Esophageal Cancer in Patients With Barrett's... placebo, defined green tea catechin extract NCT00233935 National Cancer Institute (NCI) Completed

Pages